We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Evolutionary Fitness for Codon Bias Selection Measured

By LabMedica International staff writers
Posted on 04 Apr 2016
Using bacteria as a model, researchers have for the first time quantified weak but effective selection forces that determine non-random codon usage in protein translation of RNA. More...
Quantification of codon usage bias deepens our understanding of the selective forces driving long-term genome evolution and may have applications for rational design of synthetic genes and for heterologous gene expression in biotechnology.

The genetic code is redundant, with individual amino acids being encoded by up to 6 different synonymous codons. Some codons are used more frequently than others, giving rise to codon usage bias (CUB), an important genome-shaping factor, especially among fast-growing organisms, including pathogenic bacteria and yeasts. Free-living unicellular organisms such as bacteria, which live in an environment of intense competitive selection, have an extreme CUB. Furthermore, a strong positive correlation between CUB and gene expression levels has been observed in many microorganisms. This has been attributed to selection for translational efficiency, however this putative selective advantage has never been measured in bacteria and theoretical estimates vary widely.

In the new study, graduate student Gerrit Brandis and Prof. Diarmaid Hughes of Uppsala University (Uppsala, Sweden) used Salmonella bacteria to quantitatively address the question of how large a cost-benefit difference in fitness is required for selection to be effective.

The speed of RNA to protein translation is a determining factor of bacterial growth rate. The ancient mechanism of translation has been under selection for billions of years. The researchers investigated effects of changing various codons on producing the highly expressed EF-Tu, one of the most important Salmonella proteins. By systematically mutating codons in the gene, they found that changing even a single codon to any one of the alternative synonymous codons reduced the fitness of Salmonella. This suggested that the naturally used codons are a best fit and that any codon change reduces Salmonella’s fitness in that environment.

The researchers quantified the fitness cost of changing codons in the gene. On average, changing a single codon reduced Salmonella fitness by 0.01% per generation. So a difference of only 1/100th of 1% in fitness is sufficient for evolutionary selection that underlies the phenomenon of CUB. Over very long time scales (hundreds of millions of years), evolution selects for tiny differences in relative fitness, as small or smaller than 0.01% difference per generation for Salmonella.

The study was published March 10, 2016, in the journal PLoS Genetics.

Related Links:

Uppsala University



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.